Inactivation mechanisms of influenza A virus under pH conditions encountered in aerosol particles as revealed by whole-virus HDX-MS.


Journal

mSphere
ISSN: 2379-5042
Titre abrégé: mSphere
Pays: United States
ID NLM: 101674533

Informations de publication

Date de publication:
24 10 2023
Historique:
medline: 27 10 2023
pubmed: 18 8 2023
entrez: 18 8 2023
Statut: ppublish

Résumé

Multiple respiratory viruses, including influenza A virus (IAV), can be transmitted via expiratory aerosol particles, and aerosol pH was recently identified as a major factor influencing airborne virus infectivity. Indoors, small exhaled aerosols undergo rapid acidification to pH ~4. IAV is known to be sensitive to mildly acidic conditions encountered within host endosomes; however, it is unknown whether the same mechanisms could mediate viral inactivation within the more acidic aerosol micro-environment. Here, we identified that transient exposure to pH 4 caused IAV inactivation by a two-stage process, with an initial sharp decline in infectious titers mainly attributed to premature attainment of the post-fusion conformation of viral protein haemagglutinin (HA). Protein changes were observed by hydrogen-deuterium exchange coupled to mass spectrometry (HDX-MS) as early as 10 s post-exposure to acidic conditions. Our HDX-MS data are in agreement with other more labor-intensive structural analysis techniques, such as X-ray crystallography, highlighting the ease and usefulness of whole-virus HDX-MS for multiplexed protein analyses, even within enveloped viruses such as IAV. Additionally, virion integrity was partially but irreversibly affected by acidic conditions, with a progressive unfolding of the internal matrix protein 1 (M1) that aligned with a more gradual decline in viral infectivity with time. In contrast, no acid-mediated changes to the genome or lipid envelope were detected. Improved understanding of respiratory virus fate within exhaled aerosols constitutes a global public health priority, and information gained here could aid the development of novel strategies to control the airborne persistence of seasonal and/or pandemic influenza in the future. IMPORTANCE It is well established that COVID-19, influenza, and many other respiratory diseases can be transmitted by the inhalation of aerosolized viruses. Many studies have shown that the survival time of these airborne viruses is limited, but it remains an open question as to what drives their infectivity loss. Here, we address this question for influenza A virus by investigating structural protein changes incurred by the virus under conditions relevant to respiratory aerosol particles. From prior work, we know that expelled aerosols can become highly acidic due to equilibration with indoor room air, and our results indicate that two viral proteins are affected by these acidic conditions at multiple sites, leading to virus inactivation. Our findings suggest that the development of air treatments to quicken the speed of aerosol acidification would be a major strategy to control infectious bioburdens in the air.

Identifiants

pubmed: 37594288
doi: 10.1128/msphere.00226-23
pmc: PMC10597348
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0022623

Subventions

Organisme : Swiss National Science Foundation
ID : 189939
Pays : Switzerland

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Anal Bioanal Chem. 2010 Jun;397(3):967-72
pubmed: 20195578
Biophys J. 2001 Feb;80(2):812-21
pubmed: 11159448
Microbes Environ. 2015;30(2):140-4
pubmed: 25843687
J Virol. 2011 May;85(10):5172-82
pubmed: 21367895
Emerg Infect Dis. 2006 Nov;12(11):1657-62
pubmed: 17283614
PLoS Pathog. 2020 Nov 30;16(11):e1009062
pubmed: 33253316
Protein Sci. 2005 Jun;14(6):1661-72
pubmed: 15883190
Proc Natl Acad Sci U S A. 2022 Sep 27;119(39):e2212140119
pubmed: 36037391
PLoS One. 2013 Dec 16;8(12):e82431
pubmed: 24358182
J Hyg (Lond). 1952 Dec;50(4):471-90
pubmed: 13022963
Am J Respir Crit Care Med. 2016 Aug 1;194(3):308-16
pubmed: 26890617
Clin Infect Dis. 2010 Nov 15;51(10):1176-83
pubmed: 20942655
Bioinformatics. 2011 Feb 15;27(4):572-7
pubmed: 21169379
Int J Infect Dis. 2020 Nov;100:476-482
pubmed: 32949774
Structure. 2014 Feb 4;22(2):230-7
pubmed: 24361271
Biochemistry. 1993 Mar 23;32(11):2771-9
pubmed: 8457544
EMBO J. 1990 Dec;9(13):4231-41
pubmed: 2265606
J R Soc Interface. 2009 Dec 6;6 Suppl 6:S783-90
pubmed: 19773292
Can J Microbiol. 1975 Jun;21(6):819-23
pubmed: 167927
Respir Res. 2007 May 17;8:38
pubmed: 17509128
Sci Adv. 2020 Apr 29;6(18):eaaz8822
pubmed: 32494683
Nature. 2006 Dec 21;444(7122):1078-82
pubmed: 17151603
Environ Sci Technol. 2022 Apr 5;56(7):4062-4070
pubmed: 35258957
Build Environ. 2021 Jun;196:107788
pubmed: 33746341
Protein Sci. 2001 Jun;10(6):1234-43
pubmed: 11369862
J Infect Dis. 2013 Apr;207(7):1037-46
pubmed: 23372182
FEBS Lett. 1999 Dec 17;463(3):255-9
pubmed: 10606732
Rev Med Virol. 2003 Mar-Apr;13(2):85-97
pubmed: 12627392
J Virol. 2013 May;87(10):5621-8
pubmed: 23468509
J Environ Health. 2010 Nov;73(4):22-8
pubmed: 21133312
J R Soc Interface. 2019 Jan 31;16(150):20180298
pubmed: 30958176
PLoS One. 2020 Dec 8;15(12):e0243505
pubmed: 33290421
Proc Natl Acad Sci U S A. 2022 Jul 5;119(27):e2200109119
pubmed: 35763573
J Infect Dis. 2017 Jul 1;216(1):105-109
pubmed: 28498998
J Med Virol. 2013 Dec;85(12):2151-9
pubmed: 23959825
J Aerosol Med Pulm Drug Deliv. 2011 Jun;24(3):137-47
pubmed: 21361786
J Virol. 2014 May;88(10):5617-29
pubmed: 24599998
J Occup Environ Hyg. 2015;12(2):107-13
pubmed: 25523206
PLoS Pathog. 2013 Mar;9(3):e1003205
pubmed: 23505369
Clin Infect Dis. 2012 Jun;54(11):1569-77
pubmed: 22460981
Nature. 1998 Nov 5;396(6706):92-6
pubmed: 9817207
Science. 2004 Mar 19;303(5665):1838-42
pubmed: 14764886
Structure. 2015 Apr 7;23(4):665-76
pubmed: 25773144
Virol J. 2013 Nov 22;10:321
pubmed: 24261589
Nat Med. 2020 Jun;26(6):981
pubmed: 32461699
Nat Struct Mol Biol. 2004 Jul;11(7):676-7
pubmed: 15208693
Nat Commun. 2013;4:1935
pubmed: 23736803
Nature. 2020 Jul;583(7814):150-153
pubmed: 32461688
Commun Biol. 2022 Mar 22;5(1):249
pubmed: 35318436
Influenza Other Respir Viruses. 2016 Sep;10(5):404-13
pubmed: 26991074
Int J Infect Dis. 2021 Jul;108:212-216
pubmed: 33901650
Structure. 2010 Nov 10;18(11):1483-91
pubmed: 21070947
BMC Pulm Med. 2012 Mar 21;12:11
pubmed: 22436202
J Expo Sci Environ Epidemiol. 2022 Sep;32(5):706-711
pubmed: 34408261
Virology. 2001 Jan 20;279(2):439-46
pubmed: 11162800
Biophys J. 2014 Apr 1;106(7):1447-56
pubmed: 24703306
Environ Sci Technol. 2021 Nov 2;55(21):14480-14493
pubmed: 34665598
J Gen Virol. 1988 Nov;69 ( Pt 11):2785-95
pubmed: 3183628
PLoS Pathog. 2013 Feb;9(2):e1003151
pubmed: 23459660
Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1081-1086
pubmed: 29348203
BMC Public Health. 2003 Jan 13;3:5
pubmed: 12525263
J Biol Chem. 1985 Mar 10;260(5):2973-81
pubmed: 3972812
EMBO J. 2002 Nov 1;21(21):5701-10
pubmed: 12411488
Influenza Other Respir Viruses. 2022 May;16(3):402-410
pubmed: 35037404
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Science. 2006 Jul 14;313(5784):187-91
pubmed: 16840692
Nucleic Acids Res. 2022 Jan 7;50(D1):D543-D552
pubmed: 34723319
PLoS One. 2012;7(4):e33118
pubmed: 22509254
Trends Microbiol. 2020 Jan;28(1):57-67
pubmed: 31629602
Am J Respir Crit Care Med. 2004 Jun 1;169(11):1187-90
pubmed: 14754759
Nature. 2020 Nov;587(7834):495-498
pubmed: 32908308
J Infect Dis. 1987 Sep;156(3):442-8
pubmed: 3039011
PLoS One. 2014 Oct 15;9(10):e110026
pubmed: 25333824
Emerg Microbes Infect. 2020 Dec;9(1):1415-1417
pubmed: 32496967
J Virol. 1983 Oct;48(1):239-48
pubmed: 6193286
Proc Natl Acad Sci U S A. 1982 Feb;79(4):968-72
pubmed: 6951181
Virus Res. 2002 May 10;85(2):141-9
pubmed: 12034481
Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10685-90
pubmed: 20498070
J Gen Virol. 1995 Jul;76 ( Pt 7):1541-56
pubmed: 9049361
mSphere. 2017 Oct 11;2(5):
pubmed: 29034325
J Virol. 2012 Mar;86(6):2919-29
pubmed: 22258245
Nat Commun. 2021 Mar 12;12(1):1653
pubmed: 33712573
Methods Enzymol. 2016;566:405-26
pubmed: 26791988
Environ Sci Technol. 2023 Jan 10;57(1):486-497
pubmed: 36537693

Auteurs

Shannon C David (SC)

Environmental Chemistry Laboratory, School of Architecture, Civil and Environmental Engineering, Ecole Polytechnique Fédérale de Lausanne (EPFL) , Lausanne, Switzerland.

Oscar Vadas (O)

Protein Platform, Faculty of Medicine, University of Geneva , Geneva, Switzerland.

Irina Glas (I)

Institute of Medical Virology, University of Zurich , Zürich, Switzerland.

Aline Schaub (A)

Environmental Chemistry Laboratory, School of Architecture, Civil and Environmental Engineering, Ecole Polytechnique Fédérale de Lausanne (EPFL) , Lausanne, Switzerland.

Beiping Luo (B)

Institute for Atmospheric and Climate Science, ETH Zurich , Zürich, Switzerland.

Giovanni D'angelo (G)

Laboratory of Lipid Cell Biology, School of Life Sciences, Interschool Institute of Bioengineering and Global Health Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL) , Lausanne, Switzerland.

Jonathan Paz Montoya (JP)

Laboratory of Lipid Cell Biology, School of Life Sciences, Interschool Institute of Bioengineering and Global Health Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL) , Lausanne, Switzerland.

Nir Bluvshtein (N)

Institute for Atmospheric and Climate Science, ETH Zurich , Zürich, Switzerland.

Walter Hugentobler (W)

Laboratory of Atmospheric Processes and their Impacts, School of Architecture, Civil and Environmental Engineering, Ecole Polytechnique Fédérale de Lausanne (EPFL) , Lausanne, Switzerland.

Liviana K Klein (LK)

Institute for Atmospheric and Climate Science, ETH Zurich , Zürich, Switzerland.

Ghislain Motos (G)

Laboratory of Atmospheric Processes and their Impacts, School of Architecture, Civil and Environmental Engineering, Ecole Polytechnique Fédérale de Lausanne (EPFL) , Lausanne, Switzerland.

Marie Pohl (M)

Institute of Medical Virology, University of Zurich , Zürich, Switzerland.

Kalliopi Violaki (K)

Laboratory of Atmospheric Processes and their Impacts, School of Architecture, Civil and Environmental Engineering, Ecole Polytechnique Fédérale de Lausanne (EPFL) , Lausanne, Switzerland.

Athanasios Nenes (A)

Laboratory of Atmospheric Processes and their Impacts, School of Architecture, Civil and Environmental Engineering, Ecole Polytechnique Fédérale de Lausanne (EPFL) , Lausanne, Switzerland.
Institute of Chemical Engineering Sciences, Foundation for Research and Technology Hellas , Patras, Greece.

Ulrich K Krieger (UK)

Institute for Atmospheric and Climate Science, ETH Zurich , Zürich, Switzerland.

Silke Stertz (S)

Institute of Medical Virology, University of Zurich , Zürich, Switzerland.

Thomas Peter (T)

Institute for Atmospheric and Climate Science, ETH Zurich , Zürich, Switzerland.

Tamar Kohn (T)

Environmental Chemistry Laboratory, School of Architecture, Civil and Environmental Engineering, Ecole Polytechnique Fédérale de Lausanne (EPFL) , Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH